|

Escitalopram Clinical Trials

7 actively recruiting trials across 2 locations

▼ -2 trials since August 2026

Also known as: ATC code: N06AB10, Active Comparator, Cipralex, Lexapro

Pipeline

Phase 2: 2Phase 3: 2Phase 4: 3

Top Sponsors

  • Dr. Inge Winter2
  • Vigonvita Life Sciences1
  • University of Texas Southwestern Medical Center1
  • University of Cincinnati1
  • Poznan University of Medical Sciences1

Indications

  • Depression5
  • Bipolar Depression2
  • Major Depressive Disorder2
  • Depressive Episodes1
  • Schizophrenia and Related Disorders1

Other5 trials

Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
Phase 2
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Phase 3
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
Phase 4
TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children
Phase 4
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Phase 3

Cincinnati, Ohio1 trial

Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)

University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience

Phase 4

Dallas, Texas1 trial

Escitalopram in Asthma Patients With Frequent Exacerbation

UT Southwestern, 1440 Empire Central, Ste. LD4.100

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.